Skip to main content
. 2013 May 1;13(1):1–40.

Table 5: ICER of TAVI Versus sAVR in 3-Way Sensitivity Analysesa.

Increment in Utility (TAVI
Versus sAVR)
Difference in Total Cost of TAVI Versus sAVR
-$4,642
(Base Case)
$5,358 $15,358 $25,358
Life Table Mortality After 1 Year for Both TAVI and sAVR (Base Case)
0 $46,970b Dominated Dominated Dominated
0.01 (base-case) $66,985b Dominated Dominated Dominated
0.06 Dominant $77,904 $223,313 $368,722
0.12 Dominant $22,665 $64,970 $107,275
Mortality After 1 Year of 0.25 for Both TAVI and sAVR
0 $182,700a Dominated Dominated Dominated
0.01 $588,373a Dominated Dominated Dominated
0.06 Dominant $39,465 $141,646 $243,827
0.12 Dominant $16,842 $60,448 $104,054
Mortality After 1 Year of 0.25 for SAVR and 0.24 for TAVI
0 Dominant $506,880 $1,691,211 $2,875,543
0.01 Dominant $133,845 $446,574 $759,303
0.06 Dominant $30,139 $100,561 $170,982
0.12 Dominant $15,531 $51,821 $88,110

Abbreviations: ICER, incremental cost-effectiveness ratio; sAVR, surgical aortic valve replacement; TAVI, transcatheter aortic valve implantation.

a

All amounts are in Canadian dollars.

b

The larger ICER means that TAVI is more cost-effective than sAVR (the results are in the southwest quadrant of the cost-effectiveness plane).